C69.6 Category · further specificity required Malignant neoplasm of orbit
ICD-10-CM C69.6 identifies “Malignant neoplasm of orbit” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 2: Neoplasms
Code-level instructions
Inclusion terms5
- Malignant neoplasm of connective tissue of orbit
- Malignant neoplasm of extraocular muscle
- Malignant neoplasm of peripheral nerves of orbit
- Malignant neoplasm of retrobulbar tissue
- Malignant neoplasm of retro-ocular tissue
Excludes 11
malignant neoplasm of orbital bone (C41.0)
Inherited instructions
Chapters 2 · Neoplasms (C00-D49)
Note8
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
C69 · Malignant neoplasm of eye and adnexa
More specific codes
Official index references
Official index references (11)
Neoplasm, neoplastic (11)
- Neoplasm, neoplastic › connective tissue NEC › orbitNeoplasms
- Neoplasm, neoplastic › extraocular muscleNeoplasms
- Neoplasm, neoplastic › intraorbitalNeoplasms
- Neoplasm, neoplastic › muscle › extraocularNeoplasms
- Neoplasm, neoplastic › nerve(ganglion) › peripheral NEC › orbitNeoplasms
- Neoplasm, neoplastic › orbitNeoplasms
- Neoplasm, neoplastic › orbit › autonomic nerveNeoplasms
- Neoplasm, neoplastic › orbit › eyeNeoplasms
- Neoplasm, neoplastic › orbit › peripheral nervesNeoplasms
- Neoplasm, neoplastic › orbit › soft partsNeoplasms
- Neoplasm, neoplastic › retrobulbarNeoplasms
References from other codes (3)
Excludes 1 · malignant neoplasm of peripheral nerves of orbit (C69.6-)
Excludes 1 · connective tissue of orbit (C69.6-)
Excludes 1 · retrobulbar malignant neoplasm (C69.6-)
History
Code history
No recorded change since first observation
ChangedUnchanged
FY2016
Effective from
- First observed
Malignant neoplasm of orbit
Category — select a more specific code
CDC/NCHS · FY2016All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Explore the more specific codes in this category. Reference checks do not establish clinical appropriateness or guarantee reimbursement.